Pipeline

SYGNIS has one project in a phase II efficacy clinical trial. In addition, SYGNIS has several projects in preclinical development and late discovery. Our continuously evolving pipeline focuses on CNS disorders of high unmet medical need such as stroke or cognitive deficits.

Pipeline Chart

CNS Pipeline * data packages available; continuation of programs depending on additional resources/ partnership

You are here : SYGNIS Pharma AG > CNS Program > Pipeline
Imprint Disclaimer © 2012 SYGNIS AG